These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7567013)

  • 1. Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group.
    Bradford CR; Zhu S; Wolf GT; Poore J; Fisher SG; Beals T; McClatchey KD; Carey TE
    Otolaryngol Head Neck Surg; 1995 Oct; 113(4):408-12. PubMed ID: 7567013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutation as a prognostic marker in advanced laryngeal carcinoma. Department of Veterans Affairs Laryngeal Cancer Cooperative Study Group.
    Bradford CR; Zhu S; Poore J; Fisher SG; Beals TF; Thoraval D; Hanash SM; Carey TE; Wolf GT
    Arch Otolaryngol Head Neck Surg; 1997 Jun; 123(6):605-9. PubMed ID: 9193221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation.
    Trask DK; Wolf GT; Bradford CR; Fisher SG; Devaney K; Johnson M; Singleton T; Wicha M
    Laryngoscope; 2002 Apr; 112(4):638-44. PubMed ID: 12150516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.
    Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R
    Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation.
    Wolf GT; Fisher SG
    Laryngoscope; 1992 Aug; 102(8):934-9. PubMed ID: 1495357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma.
    Bradford CR; Wolf GT; Carey TE; Zhu S; Beals TF; Truelson JM; McClatchey KD; Fisher SG
    Otolaryngol Head Neck Surg; 1999 Nov; 121(5):534-8. PubMed ID: 10547465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative surgery in T3-T4 pharyngolaryngeal squamous cell carcinoma: an alternative to radiation therapy and to total laryngectomy for good responders to induction chemotherapy.
    Lecanu JB; Monceaux G; Périé S; Angelard B; St Guily JL
    Laryngoscope; 2000 Mar; 110(3 Pt 1):412-6. PubMed ID: 10718429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group.
    Spaulding MB; Fischer SG; Wolf GT
    J Clin Oncol; 1994 Aug; 12(8):1592-9. PubMed ID: 8040671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Induction chemotherapy and larynx preservation: is such practice useful?].
    Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
    Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Larynx preservation: nonsurgical approaches].
    Bourhis J; Lefebvre JL; Temam S; Lusinchi A; Janot F; Wibault P; Pignon JP
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S24-8. PubMed ID: 15679243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of induction chemotherapy in larynx carcinoma.
    Richard JM; Sancho-Garnier H; Pessey JJ; Luboinski B; Lefebvre JL; Dehesdin D; Stromboni-Luboinski M; Hill C
    Oral Oncol; 1998 May; 34(3):224-8. PubMed ID: 9692058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preservation of the larynx in advanced cancer--experiences at the Oncology Department, Rambam Medical Center, Haifa].
    Rosenblatt E; Siegelmann-Danieli N; Zidan J; Haim N; Kuten A
    Harefuah; 2000 Oct; 139(7-8):271-4, 326. PubMed ID: 11062969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent chemoradiotherapy for organ function preservation in advanced patients with hypopharyngeal and laryngeal cancer.
    Kogashiwa Y; Yamauchi K; Nagafuji H; Matsuda T; Tsubosaka T; Tsutsumi T; Karaho T; Kohno N
    Oncol Rep; 2009 Nov; 22(5):1163-7. PubMed ID: 19787235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
    Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
    Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.
    Pointreau Y; Garaud P; Chapet S; Sire C; Tuchais C; Tortochaux J; Faivre S; Guerrif S; Alfonsi M; Calais G
    J Natl Cancer Inst; 2009 Apr; 101(7):498-506. PubMed ID: 19318632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival with preoperative chemotherapy followed by resection uncompromised by tumor response for advanced squamous cell carcinoma of the head and neck.
    Loré JM; Diaz-Ordaz E; Spaulding M; Chary K; Kaufman S; Lawrence W; Hong F; Gerold T; Sundquist N; Barrali RA
    Am J Surg; 1995 Nov; 170(5):506-11. PubMed ID: 7485744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
    Janoray G; Pointreau Y; Garaud P; Chapet S; Alfonsi M; Sire C; Jadaud E; Calais G
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26681800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional organ preservation in locally advanced laryngeal squamous cell carcinoma: is there a role for induction chemotherapy?
    Loo SW; Geropantas K; Roques TW
    Clin Oncol (R Coll Radiol); 2013 May; 25(5):298-307. PubMed ID: 23290343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.